Universal-Beteiligungs- und Servicegesellschaft’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$844K Buy
34,387
+5,030
+17% +$165K ﹤0.01% 1566
2025
Q4
$1.14M Sell
29,357
-526
-2% -$17K ﹤0.01% 1453
2025
Q3
$680K Sell
29,883
-24,727
-45% -$502K ﹤0.01% 1667
2025
Q2
$1.12M Buy
54,610
+42,857
+365% +$793K ﹤0.01% 1453
2025
Q1
$235K Buy
+11,753
New +$291K ﹤0.01% 1842

Other funds holding CSTL

Universal-Beteiligungs- und Servicegesellschaft's CSTL Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Castle Biosciences (CSTL) stake by 17% in Q1 2026, buying an estimated $165K and bringing the position to 34,387 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CSTL in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.14M in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 34,387 shares of Castle Biosciences worth $844K as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 5,030 Castle Biosciences shares in Q1 2026, an estimated $165K.
  • Castle Biosciences made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1566 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Castle Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Castle Biosciences position peaked at $1.14M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.